Estimated read time 3 min read

GlaxoSmithKline’s Arexvy vaccine shows promise in protecting adults aged 50-59 against RSV

In a significant development, GlaxoSmithKline (GSK) announced promising results from a late-stage clinical trial for their vaccine, Arexvy, which exhibits the potential to protect adults [more…]

Estimated read time 2 min read

Abbott’s Biowearable shines in successful U.K. performance

Biowearables represent a cutting-edge revolution in healthcare technology. These innovative devices are designed to monitor various physiological parameters within the human body, offering real-time insights [more…]